EE78 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment Following Complete Resection and Platinum-Based Chemotherapy in Adult Patients With Early-Stage Non-Small Cell Lung Cancer With a High Risk of Recurrence
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.350
https://www.valueinhealthjournal.com/article/S1098-3015(23)03480-0/fulltext
Title :
EE78 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment Following Complete Resection and Platinum-Based Chemotherapy in Adult Patients With Early-Stage Non-Small Cell Lung Cancer With a High Risk of Recurrence
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03480-0&doi=10.1016/j.jval.2023.09.350
First page :
Section Title :
Open access? :
No
Section Order :
12375